Search Results 1301-1310 of 16369 for substance P
Raquel P; Olenchock BA. Benjamin A; Lichtman AH. Andrew H; Roden DM. Dan M; Seidman CE. Christine E; Koralnik IJ. Igor J; Seidman JG. Jonathan G; Hoffman RD ...
The primary purpose of this study is to evaluate the effectiveness of BG00011 compared with placebo in participants with Idiopathic Pulmonary Fibrosis (IPF).
Find a doctor whose last name begins with the letter P P; There are no doctors whose last name begins with the letter Q Q; Find a doctor whose last name ...
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
Abu Dabrh AM, Farah WH, McLeod HM, Biazar P, Mohabbat AB, Munipalli B, Garofalo R, Stroebel RJ, Shah N, Angstman KB, Presutti RJ, Farford B, Horn JL, Allen ...
Fulvicin P/G. Also known as. Griseofulvin (oral route). Fulvicin-U/F. Also known as. Griseofulvin (oral route). Fung-O. Also known as. Salicylic acid (topical ...
There are no doctors whose last name begins with the letter P P; There are no doctors whose last name begins with the letter Q Q; There are no doctors whose ...
5 years or longer s/p definitive management for head and neck cancer; ... Less than 5 years s/p ... Active substance use within 6 months. Pregnancy ...
Diuretics: A cause of low potassium? Drug addiction (substance use disorder) · Exercise: A drug-free approach to lowering high blood pressure · Free blood ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!